Identification of prostate cancer specific methylation biomarkers from a multi-cancer analysis

BACKGROUND: Detecting prostate cancer at a non-aggressive stage is the main goal of prostate cancer screening. DNA methylation has been widely used as biomarkers for cancer diagnosis and prognosis, however, with low clinical translation rate. By taking advantage of multi-cancer data from The Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Yiyi, Li, Chao, Yuan, Haining, Wang, Xiaoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507340/
https://www.ncbi.nlm.nih.gov/pubmed/34641790
http://dx.doi.org/10.1186/s12859-021-04416-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507340/
https://www.ncbi.nlm.nih.gov/pubmed/34641790
http://dx.doi.org/10.1186/s12859-021-04416-w

Ejemplares similares